BOVINE TISSUE-DERIVED DIETARY SUPPLEMENT MANUFACTURERS, IMPORTERS
This article was originally published in The Tan Sheet
Executive Summary
BOVINE TISSUE-DERIVED DIETARY SUPPLEMENT MANUFACTURERS, IMPORTERS and cosmetics manufacturers and importers are being urged by FDA to develop "plans for ensuring, with a high degree of certainty, that specific bovine-derived materials" from countries where bovine spongiform encephalopathy (BSE) exists "are not used." In an Aug. 17 open letter to "manufacturers and importers" of dietary supplements and cosmetics, FDA Interim Deputy Commissioner for Operations Linda Suydam alerted companies to the need of avoiding bovine tissues or extracts from countries where BSE, a transmissible, "uniformly fatal" neurological disease, has been reported.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning